Trending

Ultragenyx

FDA backs second rare disease drug from Ultragenyx in the space of a fortnight

FDA backs second rare disease drug from Ultragenyx in the space of a fortnight

The FDA has approved a second rare disease drug from California-based Ultragenyx in the space of a fortnight, for treatment

X

FDA backs second rare disease drug from Ultragenyx in the space of a fortnight

https://pharmaphorum.com/news/fda-backs-ultragenyxs-second-rare-disease-drug-in-the-space-of-a-fortnight/

Key payer backs Ultragenyx’ rare rickets drug at $200,000 per year

Key payer backs Ultragenyx’ rare rickets drug at $200,000 per year

Express Scripts’ Miller backs “responsible” price

X

Key payer backs Ultragenyx’ rare rickets drug at $200,000 per year

https://pharmaphorum.com/sales-marketing/key-payers-backs-ultragenyx-rare-rickets-drug-200000-per-year/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com